Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Mercurio (Baltimore, United States of America), N. Diab (Ottawa, Canada), G. Peloquin (Baltimore, United States of America), T. Housten-Harris (Baltimore, United States of America), R. Damico (Baltimore, United States of America), T. Kolb (Baltimore, United States of America), S. Mathai (Baltimore, United States of America), P. Hassoun (Baltimore, United States of America). ESC/ERS low-risk profile achievement accurately predicts mortality in scleroderma-associated PAH. 270

Member's Comments

No comment yet.

Related content which might interest you: emPHasis-10 score predicts mortality in patients with pulmonary hypertension Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 FEV1/Height2 could be a better alternative than FEV1 in predicting all cause mortality in patients with COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 A dynamic prognostic model to predict survival and determine treatment goals in pulmonary arterial hypertension (PAH): the EFORT study Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1602520; DOI: 10.1183/13993003.02520-2016 Year: 2017 A clinical scoring algorithm to predict all cause mortality in COPD Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018 Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease Source: Eur Respir J, 58 (3) 2004133; 10.1183/13993003.04133-2020 Year: 2021 Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Comparison of predictive respiratory function parameters of lung cancer patients having COPD diagnosis with postoperative values and relation with mortality and morbidity Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Validation of bode index as a predictor of mortality in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 Assessment of pulmonary function stratifies global coronary heart disease risk Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004 Does improvement in health status affect long term mortality in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 248s Year: 2002 Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD? Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Complexity of the relationship between cardiovascular co-morbidity, multi-dimensional assessment and mortality in a primary care cohort with COPD Source: Annual Congress 2007 - COPD and comorbidity Year: 2007